Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Processa Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +4 vs. Q1 2025
- Shares held
- 372.6K
- +201.8K (+118.2%) vs. Q1 2025
- Total value
- $75.9K
- +$12.7K (+20.1%) vs. Q1 2025
- New holders
- 6
- 4 more added
- Sold out
- 2
- 1 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $498.3K |
| Q1 2026 | 10 | $448.5K |
| Q4 2025 | 10 | $331.0K |
| Q3 2025 | 14 | $341.9K |
| Q2 2025 | 13 | $75.9K |
| Q1 2025 | 9 | $63.2K |
| Q4 2024 | 8 | $87.5K |
| Q3 2024 | 8 | $66.5K |
| Q2 2024 | 9 | $101.0K |
| Q1 2024 | 11 | $251.5K |
| Q4 2023 | 18 | $376.5K |
| Q3 2023 | 20 | $349.8K |
| Q2 2023 | 19 | $691.4K |
| Q1 2023 | 22 | $852.6K |
| Q4 2022 | 18 | $1.28M |
| Q3 2022 | 18 | $2.58M |
| Q2 2022 | 18 | $3.24M |
| Q1 2022 | 18 | $3.22M |
| Q4 2021 | 19 | $6.47M |
| Q3 2021 | 18 | $12.2M |
| Q2 2021 | 18 | $11.2M |
| Q1 2021 | 17 | $12.3M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Processa Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 104,723 | $21.0K | 0.00% | +61,494+142.3% | Added |
| UBS Group AG | 64,612 | $13.2K | 0.00% | +64,556+115,278.6% | Added |
| Alpine Global Management, LLC | 53,416 | $10.9K | 0.00% | +53,416 | New |
| Geode Capital Management, LLC | 50,573 | $10.4K | 0.00% | +16,160+47.0% | Added |
| Cubist Systematic Strategies, LLC | 41,848 | $8.58K | 0.00% | +41,848 | New |
| Vanguard Group Inc | 24,433 | $5.01K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 19,270 | $3.95K | 0.00% | +19,270 | New |
| Sequoia Financial Advisors, LLC | 11,000 | $2.25K | 0.00% | +11,000 | New |
| Tower Research Capital LLC (TRC) | 2,462 | $505 | 0.00% | −5−0.2% | Reduced |
| Wells Fargo & Company | 154 | $32 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 108 | $22 | 0.00% | +71+191.9% | Added |
| SBI Securities Co., Ltd. | 12 | $2 | 0.00% | +12 | New |
| Advisor Group Holdings, Inc. | 2 | $0 | 0.00% | +2 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −56,000−100.0% | Sold out |
| Miracle Mile Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |